XML 45 R13.htm IDEA: XBRL DOCUMENT
v2.4.0.6

ACCRUED LIABILITIES AND OTHER CURRENT LIABILITIES | 9 Months Ended
--- | ---
Sep. 30, 2012
ACCRUED LIABILITIES AND OTHER CURRENT LIABILITIES |
ACCRUED LIABILITIES AND OTHER CURRENT LIABILITIES |
6. ACCRUED LIABILITIES AND OTHER CURRENT LIABILITIES Accrued and other current liabilities consisted of the following:
|  | December 31, 2011 |  | September 30, 2012 |
|  | ($000s) |
Accrued research and development. |  | 3,621 |  | 3,335 |
Other current liabilities |  | 562 |  | 792 |
|  | 4,183 |  | 4,127 |
During the nine months ended September 30, 2012, the Company recorded out of period reversals of pre-clinical expense accruals of $0.4 million as a decrease to accrued liabilities and other current liabilities on the consolidated balance sheets and as a decrease to research and development expenses on the consolidated statements of operations.

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References No definition available. + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration